CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
Europe - OSL:CONTX - SE0014731154 - Common Stock
3.78 NOK
+0.02 (+0.53%)
Taking everything into account, CONTX scores 5 out of 10 in our fundamental rating. CONTX was compared to 12 industry peers in the Health Care Technology industry. While CONTX has a great profitability rating, there are some minor concerns on its financial health. CONTX has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CONTX was profitable.
CONTX had a positive operating cash flow in the past year.
CONTX had positive earnings in 4 of the past 5 years.
In the past 5 years CONTX always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.66%, CONTX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CONTX has a Return On Equity of 10.25%. This is comparable to the rest of the industry: CONTX outperforms 58.33% of its industry peers.
CONTX has a better Return On Invested Capital (8.96%) than 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CONTX is significantly above the industry average of 9.21%.
The 3 year average ROIC (36.72%) for CONTX is well above the current ROIC(8.96%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROIC | 8.96% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
CONTX has a Profit Margin (7.86%) which is in line with its industry peers.
CONTX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 9.33%, CONTX is in line with its industry, outperforming 58.33% of the companies in the same industry.
CONTX's Operating Margin has improved in the last couple of years.
CONTX has a Gross Margin of 97.46%. This is amongst the best in the industry. CONTX outperforms 91.67% of its industry peers.
CONTX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CONTX is creating value.
The number of shares outstanding for CONTX remains at a similar level compared to 1 year ago.
CONTX has about the same amout of shares outstanding than it did 5 years ago.
CONTX has a worse debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of CONTX is 1.49, which is an excellent value as it means it would take CONTX, only 1.49 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 1.49, CONTX perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
CONTX has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
CONTX has a better Debt to Equity ratio (0.07) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | N/A |
ROIC/WACC1.27
WACC7.07%
2.3 Liquidity
A Current Ratio of 4.12 indicates that CONTX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.12, CONTX belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
CONTX has a Quick Ratio of 4.07. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.07, CONTX belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 |
3. Growth
3.1 Past
The earnings per share for CONTX have decreased strongly by -64.19% in the last year.
The Earnings Per Share has been growing by 27.26% on average over the past years. This is a very strong growth
CONTX shows a decrease in Revenue. In the last year, the revenue decreased by -9.99%.
The Revenue has been growing slightly by 6.51% on average over the past years.
EPS 1Y (TTM)-64.19%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-12.48%
3.2 Future
Based on estimates for the next years, CONTX will show a decrease in Earnings Per Share. The EPS will decrease by -3.57% on average per year.
Based on estimates for the next years, CONTX will show a small growth in Revenue. The Revenue will grow by 0.49% on average per year.
EPS Next Y-100%
EPS Next 2Y-33.05%
EPS Next 3Y-3.57%
EPS Next 5YN/A
Revenue Next Year-6.41%
Revenue Next 2Y-2.61%
Revenue Next 3Y-1.08%
Revenue Next 5Y0.49%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 29.08, the valuation of CONTX can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CONTX indicates a somewhat cheap valuation: CONTX is cheaper than 66.67% of the companies listed in the same industry.
CONTX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.35.
With a Price/Forward Earnings ratio of 26.57, CONTX can be considered very expensive at the moment.
66.67% of the companies in the same industry are more expensive than CONTX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CONTX to the average of the S&P500 Index (33.72), we can say CONTX is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.08 | ||
| Fwd PE | 26.57 |
4.2 Price Multiples
CONTX's Enterprise Value to EBITDA ratio is in line with the industry average.
CONTX's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 46.81 | ||
| EV/EBITDA | 11.09 |
4.3 Compensation for Growth
The decent profitability rating of CONTX may justify a higher PE ratio.
CONTX's earnings are expected to decrease with -3.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.07
EPS Next 2Y-33.05%
EPS Next 3Y-3.57%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
CONTX's Dividend Yield is rather good when compared to the industry average which is at 3.53. CONTX pays more dividend than 83.33% of the companies in the same industry.
CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-33.05%
EPS Next 3Y-3.57%
OSL:CONTX (11/12/2025, 4:01:43 PM)
3.78
+0.02 (+0.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap292.46M
Revenue(TTM)119.16M
Net Income(TTM)9.36M
Analysts40
Price Target5.1 (34.92%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-124.27%
Min EPS beat(2)-148.54%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.12%
Min Revenue beat(2)-29.34%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)100%
EPS NY rev (3m)-100%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.08 | ||
| Fwd PE | 26.57 | ||
| P/S | 2.31 | ||
| P/FCF | 46.81 | ||
| P/OCF | 20.19 | ||
| P/B | 3.01 | ||
| P/tB | 3.11 | ||
| EV/EBITDA | 11.09 |
EPS(TTM)0.13
EY3.44%
EPS(NY)0.14
Fwd EY3.76%
FCF(TTM)0.08
FCFY2.14%
OCF(TTM)0.19
OCFY4.95%
SpS1.64
BVpS1.25
TBVpS1.22
PEG (NY)N/A
PEG (5Y)1.07
Graham Number1.92
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROCE | 11.34% | ||
| ROIC | 8.96% | ||
| ROICexc | 31.76% | ||
| ROICexgc | 35.3% | ||
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% | ||
| FCFM | 4.93% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 96.94% | ||
| Cap/Sales | 6.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.3% | ||
| Profit Quality | 62.81% | ||
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 | ||
| Altman-Z | N/A |
F-Score5
WACC7.07%
ROIC/WACC1.27
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.19%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
EPS Next Y-100%
EPS Next 2Y-33.05%
EPS Next 3Y-3.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-12.48%
Revenue Next Year-6.41%
Revenue Next 2Y-2.61%
Revenue Next 3Y-1.08%
Revenue Next 5Y0.49%
EBIT growth 1Y-64.61%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-32.14%
EBIT Next 3Y9.74%
EBIT Next 5YN/A
FCF growth 1Y-82.88%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-68.39%
OCF growth 3Y51.49%
OCF growth 5Y5.6%
CONTEXTVISION AB / CONTX.OL FAQ
What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.
What is the valuation status of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a valuation rating of 3 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.
How profitable is CONTEXTVISION AB (CONTX.OL) stock?
CONTEXTVISION AB (CONTX.OL) has a profitability rating of 7 / 10.
How financially healthy is CONTEXTVISION AB?
The financial health rating of CONTEXTVISION AB (CONTX.OL) is 6 / 10.
Can you provide the expected EPS growth for CONTX stock?
The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -100% in the next year.